Comparison of MY09/11 consensus PCR and type-specific PCRs in the detection of oncogenic HPV types
about
Distribution patterns of infection with multiple types of human papillomaviruses and their association with risk factorsClassical risk factors, but not HPV status, predict survival after chemoradiotherapy in advanced head and neck cancer patients.Notch is a critical regulator in cervical cancer by regulating Numb splicing.Nucleic acid sequence-based amplification assay for human papillomavirus mRNA detection and typing: evidence for DNA amplification.Identification of protein biomarkers for cervical cancer using human cervicovaginal fluidDiagnosis of 25 genotypes of human papillomaviruses for their physical statuses in cervical precancerous/cancerous lesions: a comparison of E2/E6E7 ratio-based vs. multiple E1-L1/E6E7 ratio-based detection techniquesHigh-resolution melting molecular signatures for rapid identification of human papillomavirus genotypesAssociation of Trichomonas vaginalis and cytological abnormalities of the cervix in low risk women.Combined analysis of HPV DNA, p16, p21 and p53 to predict prognosis in patients with stage IV hypopharyngeal carcinomaHuman papillomavirus detection from human immunodeficiency virus-infected Colombian women's paired urine and cervical samplesChanges in type-specific human papillomavirus load predict progression to cervical cancer.Quality control for normal liquid-based cytology: rescreening, high-risk HPV targeted reviewing and/or high-risk HPV detection?Serial type-specific human papillomavirus (HPV) load measurement allows differentiation between regressing cervical lesions and serial virion productive transient infections.Clinical validation of a type-specific real-time quantitative human papillomavirus PCR against the performance of hybrid capture 2 for the purpose of cervical cancer screening.Molecular diagnosis and phylogenetic analysis of human papillomavirus type-16 from suspected patients in PakistanEpidemiologic approaches to evaluating the potential for human papillomavirus type replacement postvaccination.Human papillomavirus genotyping and integration in ovarian cancer Saudi patients.High-risk HPV genotypes and P16INK4a expression in a cohort of head and neck squamous cell carcinoma patients in Singapore.Human papillomavirus infections in laryngeal cancer.Viral infections and colorectal cancer: a systematic review of epidemiological studies.Reliable detection of human papillomavirus in recurrent laryngeal papillomatosis and associated carcinoma of archival tissue.Molecular approaches for HPV genotyping and HPV-DNA physical status.Molecular tests potentially improving HPV screening and genotyping for cervical cancer prevention.Human Papillomavirus Genotypes and Methylation of CADM1, PAX1, MAL and ADCYAP1 Genes in Epithelial Ovarian Cancer PatientsLinear viral load increase of a single HPV-type in women with multiple HPV infections predicts progression to cervical cancer.Cervical Infection With Vaccine-Associated Human Papillomavirus (HPV) Genotypes as a Predictor of Acquisition and Clearance of Other HPV Infections.Multiplex PCR assay for the rapid identification of human papillomavirus genotypes 16, 18, 45, 35, 66, 33, 51, 58, and 31 in clinical samples.High-risk human papillomavirus infection in different histological subtypes of renal cell carcinoma.Circulation of human papillomavirus (HPV) genotypes in women from Córdoba, Argentina, with squamous intraepithelial lesions.Prevalence of human papillomavirus and Epstein-Barr virus DNA in penile cancer cases from Brazil.Effectiveness of HPV 16 viral load and the E2/E6 ratio for the prediction of cervical cancer risk among Chinese women.Prevalence and types of high-risk human papillomaviruses in head and neck cancers from Bangladesh.Human papillomavirus in semen and the risk for male infertility: a systematic review and meta-analysis.Candidate biomarkers in the cervical vaginal fluid for the (self-)diagnosis of cervical precancer.Prevalence of High-Risk Human Papillomavirus in Tonsil Tissue in Healthy Adults and Colocalization in Biofilm of Tonsillar Crypts.Clinical and analytical performance of the BD Onclarity™ HPV assay for detection of CIN2+ lesions on SurePath samples.Low prevalence of HPV-driven head and neck squamous cell carcinoma in North-East Italy.High prevalence of high-risk human papillomavirus in palatine tonsils from healthy children and adults.Clinical performance assessment of five human papillomavirus DNA tests using liquid-based cytology samples.Human papillomavirus DNA strongly correlates with a poorer prognosis in oral cavity carcinoma.
P2860
Q28742649-CDC1D1A9-1797-42DB-96A8-B3717188281EQ30373904-07B7D580-EF5D-4760-B553-EC3A0F9EE1A9Q33598695-5C48EFAF-E741-4AC1-839D-5C407AC9413FQ33963645-B19FED8E-4B24-4888-B9B1-848970C786A2Q34172304-D81EC41B-0CC1-46C0-B433-A54D0C352062Q34317107-759F593E-8879-4B8B-B574-EEA65DB4758EQ34390791-3185D35B-3972-4EDA-9624-96241B1C70FCQ34395532-32C1063F-6359-4B4A-9618-9002ED29E187Q34462878-F7C83900-1F36-4D6E-B6A7-F5ACAD6A328CQ34590155-A77271D4-407E-4882-8E43-4F75D95B80D5Q35370456-5BDA9707-58EF-4780-A222-AF2D72F26876Q35893481-408B2209-96D4-4103-9695-61FEA45E80A3Q36023925-D8C15F54-B5DE-4B59-B8FD-DA80C495A6BAQ36414150-72F426FE-3534-4342-96AF-6DD0A715C1C8Q36457679-622A3BDA-D498-4400-865E-F6789126952AQ37078556-7CAB54E8-8CF2-4BAF-9B29-D0143CAD4873Q37348056-0B4A1E47-CE56-4422-A12B-CF6FD956A013Q37699325-0201822D-00AE-4708-B266-BE68DD3E7FA1Q37789678-EF370BEF-46C4-4692-98BD-DE499B1908F8Q38245947-016F7D64-6115-4683-B5FA-589D3393EE77Q38388049-8D8F4D6A-AA3C-484D-AB07-0D49B7E629E7Q39120200-060AB5DE-37C0-4F51-B194-97BB479D1E78Q39170424-54FB28B2-ADE9-4A88-8116-282B0A5332F8Q40316397-4C4C1145-96C0-430B-A7B7-3C09222B2802Q40638281-427C4658-2A26-4C3D-A8FA-FA8DFD77232EQ40647908-CE0028BA-0151-40C2-AC7B-493ECE25985BQ41689179-5828D6E1-827D-4CD4-A488-F3EC4E4E1C6CQ42226942-21AB25D1-76AA-461C-BEE9-0A29CF2A8A35Q45125142-33FD52E8-5D2A-4A7F-89B5-538EF52185FDQ45359862-31D40DF3-0DEE-49E1-98F3-518DBC392550Q45903948-4978DB5D-C632-42D3-9B1F-28B37F28AE2BQ47099123-FB0630E3-297B-45F3-A662-F235834D67D5Q47128102-97AEABE6-4CEE-4A48-B637-0E0D73A697C6Q47397671-7A35E001-F6B4-4502-B9A3-DFE7B0C18054Q47548777-6840B198-163C-4857-BEA5-2A8A70024115Q47599053-EEB55D57-D4E7-43C2-AD08-FEEC217A690CQ47599117-960AF6AF-40C3-4605-A96D-2592F4C2FFCDQ51039855-A642CA43-8113-468C-9ECC-D0639E9CECBEQ51543570-7DADB2F0-67E5-4F6E-9623-88E15DB2C1FBQ54312966-80BFC11A-B4FF-472D-A553-933C72B8ED34
P2860
Comparison of MY09/11 consensus PCR and type-specific PCRs in the detection of oncogenic HPV types
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Comparison of MY09/11 consensu ...... tection of oncogenic HPV types
@en
Comparison of MY09/11 consensu ...... ection of oncogenic HPV types.
@nl
type
label
Comparison of MY09/11 consensu ...... tection of oncogenic HPV types
@en
Comparison of MY09/11 consensu ...... ection of oncogenic HPV types.
@nl
prefLabel
Comparison of MY09/11 consensu ...... tection of oncogenic HPV types
@en
Comparison of MY09/11 consensu ...... ection of oncogenic HPV types.
@nl
P2093
P2860
P1476
Comparison of MY09/11 consensu ...... tection of oncogenic HPV types
@en
P2093
A J Vereecken
C A J Horvath
C E Depuydt
G A V Boulet
J J Bogers
P2860
P304
P356
10.1111/J.1582-4934.2007.00073.X
P577
2007-07-01T00:00:00Z